Therapeutic Effect of PEGylated Phytosomes Loaded with Herbal Drugs for Treating Paediatric Leukaemia
Abstract
To treat pediatric leukemia, this study evaluated a co-encapsulated pegylated phytosome system based on herbal anti-cancer medications. In this study, herbal drug-soy lecithin complex-loaded phytosomes were prepared as drug carriers to overcome the limitations of natural drugs like poor absorption, low oral bioavailability, poor aqueous solubility, and so on. This is a targeted nano-drug delivery that enhances the absorption and bioavailability of the herbal drug used. In this study, herbal drug-soy lecithin complex-loaded phytosomes were further surface-functionalized with PEG as drug carriers to overcome these limitations and achieve reduced toxicity and a superior herbal drug-mediated therapeutic effect. PEGylation can help the phytosomes avoid rapid clearance from the systemic circulation by the reticuloendothelial system (RES) and increase their passive targeting effectiveness. To do this, a postinsertion approach was used to inject PEG into the lipid moiety of the phytosomes. The generated PEG-functionalized drug-loaded phytosomes feature spherical shapes, steady zeta potential values, very low PDI values, and sustained drug release while improving the therapeutic action of herbal drugs.
Full Text:
PDFReferences
Shah A, Andersson TML, Rachet B, Björkholm M, Lambert PC. Survival and cure of acute myeloid leukaemia in England, 1971–2006: a population-based study. Br J Haematol. 2013; 162(4):509–16. DOI: 10.1111/bjh.12425.
2 De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 2016;6(7):e441-. DOI: 10.1038/bcj.2016.50.
Meyers J, Yu Y, Kaye JA, Davis KL. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs. Appl Health Econ Health Policy. 2013;11(3):275–86. DOI: 10.1007/s40258–013–0032–2.
Parikh SA, Jabbour E, Koller CA. Adult acute myeloid leukemia adult acute myeloid leukemia: introduction epidemiology, etiology, and risk factors. In: MD Anderson manual of medical oncology; 2014. p. 1–25.
Hernández C. Leucemia mieloide aguda: diagnóstico, estudio y tratamiento. Manual de prácticas médicas-hospital hermanos ameijeiras. La Habana; 2006.
Pavone V, Riccioli M, Testa G, Lucenti L, De Cristo C, Condorelli G et al. Surgical treatment of displaced supracondylar pediatric humerus fractures: comparison of two pinning techniques. J Funct Morphol Kinesiol. 2016;1(1):39–47. DOI: 10.3390/jfmk1010039.
Majchrzak A, More PHB, Faraj S. Transcending knowledge differences in cross-functional teams. Organ Sci. 2012;23(4):951–70. DOI: 10.1287/orsc.1110.0677.
Tapiero H, Tew KD, Ba GN, Mathé G. Polyphenols: do they play a role in the prevention of human pathologies? Biomed Pharmacother. 2002;56(4):200–7. DOI: 10.1016/s0753–3322(02)00178–6.
Sak K. Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn Rev. 2014;8(16):122–46. DOI: 10.4103/0973–7847.134247.
Huang MY, Zhang LL, Ding J, Lu JJ. Anticancer drug discovery from Chinese medicinal herbs. Chin Med. 2018;13(1):35. DOI: 10.1186/s13020–018–0192-y.
Amawi H, Ashby CR, Tiwari AK. Cancer chemoprevention through dietary flavonoids: what’s limiting? Chin J Cancer. 2017; 36(1):50. DOI: 10.1186/s40880–017–0217–4.
Kumar V, Bhatt PC, Rahman M, Kaithwas G, Choudhry H, Al-Abbasi FA, et al. Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in the treatment of hepatocellular carcinoma: in vitro and in vivo studies. Int J Nanomedicine. 2017;12:6747–58. DOI: 10.2147/IJN.S136629.
Li Y, Wu H, Jia M, Cui F, Lin J, Yang X et al. Therapeutic effect of folate-targeted and pegylated phytosomes loaded with a Mitomycin C–soybean phosphatidyhlcholine complex. Mol Pharm. 2014;11(9):3017–26. DOI: 10.1021/mp5001873.
Harborne JB. Classes and functions of secondary products from plants. Chem Plants. 1999; 26:
–25.
Kashyap D, Tuli HS, Yerer MB, Sharma A, Sak K, Srivastava S et al. Natural product-based nanoformulations for cancer therapy: opportunities and challenges. Semin Cancer Biol. 2021, February;69. DOI: 10.1016/j.semcancer.2019.08.014.
Ahmed E, Arshad M, Khan MZ, Amjad MS, Sadaf HM, Riaz I, et al. Secondary metabolites and their multidimensional prospective in plant life. J Pharmacogn Phytochem. 2017; 6(2):205–14.
Pandey P, Rahman M, Bhatt PC, Beg S, Paul B, Hafeez A, et al. Implication of nano-antioxidant therapy for treatment of hepatocellular carcinoma using PLGA nanoparticles of rutin. Nanomedicine (Lond). 2018; 13(8):849–70. DOI: 10.2217/nnm-2017–0306.
Zare-Zardini H, Alemi A, Taheri-Kafrani A, Hosseini SA, Soltaninejad H, Hamidieh AA et al. Assessment of a new ginsenoside Rh2 nanoniosomal formulation for enhanced antitumor efficacy on prostate cancer: an in vitro study. Drug Des Dev Ther. 2020; 14:3315–24. DOI: 10.2147/DDDT.S261027.
Dave V, Gupta A, Singh P, Gupta C, Sadhu V, Reddy KR. Synthesis and characterization of celecoxib loaded pegylated liposome nanoparticles for biomedical applications. Nano Struct Nano Objects. 2019; 18:100288. DOI: 10.1016/j.nanoso.2019.100288.
El-Far SW, Helmy MW, Khattab SN, Bekhit AA, Hussein AA, Elzoghby AO. Folate conjugated vs pegylated phytosomal casein nanocarriers for codelivery of fungal- and herbal-derived anticancer drugs. Nanomedicine (Lond). 2018; 13(12):1463–80. DOI: 10.2217/nnm-2018–0006.
Shah NB, Vercellotti GM, White JG, Fegan A, Wagner CR, Bischof JC. Blood–nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties. Mol Pharm. 2012;9(8):2146–55. DOI: 10.1021/mp200626j.
Kesharwani P, Gorain B, Low SY, Tan SA, Ling ECS, Lim YK et al. Nanotechnology based approaches for anti-diabetic drugs delivery. Diabetes Res Clin Pract. 2018; 136:52–77. DOI: 10.1016/j.diabres.2017.11.018.
Rajendran I, Dhandapani H, Anantanarayanan R, Rajaram R. Apigenin mediated gold nanoparticle synthesis and their anti-cancer effect on human epidermoid carcinoma (A431) cells. RSC Adv. 2015;5(63):51055–66. DOI: 10.1039/C5RA04303D.
Suresh K, Nangia A. Curcumin: pharmaceutical solids as a platform to improve solubility and bioavailability. CrystEngComm. 2018; 20(24):3277–96. DOI: 10.1039/C8CE00469B.
Jantová S, Cipák L, Cernáková M, Kost’álová D. Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. J Pharm Pharmacol. 2003;55(8):1143–9. DOI: 10.1211/002235703322277186.
Liu CS, Zheng YR, Zhang YF, Long XY. Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia. 2016; 109:274–82. DOI: 10.1016/j.fitote.2016.02.001.
Ayesa U, Gray BD, Pak KY, Chong PLG. Liposomes containing lipid-soluble Zn(II)–bis-dipicolylamine derivatives show potential to be targeted to phosphatidylserine on the surface of cancer cells. Mol Pharm. 2017;14(1):147–56. DOI: 10.1021/acs.molpharmaceut.6b00760.
Williams J, Lansdown R, Sweitzer R, Romanowski M, LaBell R, Ramaswami R et al. Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors. J Control Release. 2003;91(1–2):167–72. DOI: 10.1016/s0168–3659(03)00241–4.
Thangapazham RL, Puri A, Tele S, Blumenthal R, Maheshwari RK. Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol. 2008;32(5):1119–23. DOI: 10.3892/ijo.32.5.1119.
Mukerjee A, Vishwanatha JK. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 2009; 29(10):3867–75.
Li J, Wang Y, Yang C, Wang P, Oelschlager DK, Zheng Y et al. Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1. Mol Pharmacol. 2009; 76(1):81–90. DOI: 10.1124/mol.109.054551.
Zu YG, Yuan S, Zhao XH, Zhang Y, Zhang XN, Jiang R. Preparation, activity and targeting ability evaluation in vitro on folate mediated epigallocatechin-3-gallate albumin nanoparticles. Yao Xue Xue Bao. 2009; 44(5): 525–31.
Ban E, Park M, Jeong S, Kwon T, Kim EH, Jung K et al. Poloxamer-based thermoreversible gel for topical delivery of emodin: influence of P407 and P188 on solubility of emodin and its application in cellular activity screening. Molecules. 2017; 22(2):246. DOI: 10.3390/molecules22020246.
Chen R, Wang S, Zhang J, Chen M, Wang Y. Aloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer study. Drug Deliv. 2015; 22(5):666–74. DOI: 10.3109/10717544.2014.882446.
Agarawal K, Anant Kulkarni Y, Wairkar S. Nanoformulations of flavonoids for diabetes and microvascular diabetic complications. Drug Deliv Transl Res. 2023; 13(1):18–36. DOI: 10.1007/s13346–022–01174-x.
Mukherjee B, Banerjee S, Mondal L, Chakraborty S, Chanda D, Perera JAC. Bioactive flavonoid apigenin and its nanoformulations: a promising hope for diabetes and cancer. In: Nanomedicine for bioactives. Singapore: Springer; 2020. p. 367–82.
Wang X, Wang Y. Ginsenoside Rh2 mitigates pediatric leukemia through suppression of Bcl-2 in leukemia cells. Cell Physiol Biochem. 2015;37(2):641–50. DOI: 10.1159/000430383.
Jin S, Fu S, Han J, Jin S, Lv Q, Lu Y et al. Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles. J Drug Target. 2012;20(7):615–22. DOI: 10.3109/1061186X.2012.702770.
Mishra D, Jain N, Rajoriya V, Jain AK. Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine. J Pharm Pharmacol. 2014; 66(8):1082–93. DOI: 10.1111/jphp.12235.
Gera S, Talluri S, Rangaraj N, Sampathi S. Formulation and evaluation of naringenin nanosuspensions for bioavailability enhancement. AAPS PharmSciTech. 2017; 18(8):3151–62. DOI: 10.1208/s12249–017–0790–5.
Taghipour YD, Hajialyani M, Naseri R, Hesari M, Mohammadi P, Stefanucci A et al. Nanoformulations of natural products for management of metabolic syndrome. Int J Nanomedicine. 2019;14:5303–21. DOI: 10.2147/IJN.S213831.
Figueiró F, Bernardi A, Frozza RL, Terroso T, Zanotto-Filho A, Jandrey EH et al. Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth. J Biomed Nanotechnol. 2013;9(3):516–26. DOI: 10.1166/jbn.2013.1547.
Wang J, Li G, Rui T, Kang A, Li G, Fu T et al. Pharmacokinetics of rosmarinic acid in rats by LC-MS/MS: absolute bioavailability and dose proportionality. RSC Adv. 2017; 7(15):9057–63. DOI: 10.1039/C6RA28237G.
El-Far YM, Zakaria MM, Gabr MM, El Gayar AM, El-Sherbiny IM, Eissa LA. A newly developed silymarin nanoformulation as a potential antidiabetic agent in experimental diabetes. Nanomedicine (Lond). 2016; 11(19):2581–602. DOI: 10.2217/nnm-2016–0204.
Ochi MM, Amoabediny G, Rezayat SM, Akbarzadeh A, Ebrahimi B. In vitro co-delivery evaluation of novel pegylated nano-liposomal herbal drugs of silibinin and glycyrrhizic acid (nano-phytosome) to hepatocellular carcinoma cells. Cell J. 2016;18(2):135–48. DOI: 10.22074/cellj.2016.4308.
Mukhopadhyay P, Prajapati AK. Quercetin in anti-diabetic research and strategies for improved quercetin bioavailability using polymer-based carriers – a review. RSC Adv. 2015;5(118):97547–62. DOI: 10.1039/C5RA18896B.
Minaei A, Sabzichi M, Ramezani F, Hamishehkar H, Samadi N. Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells. Mol Biol Rep. 2016;43(2):99–105. DOI: 10.1007/s11033–016–3942-x.
Click ZR, Seddon AN, Bae YR, Fisher JD, Ogunniyi A. New Food and Drug Administration–approved and emerging novel treatment options for acute myeloid leukemia. Pharmacotherapy. 2018;38(11):1143–54. DOI: 10.1002/phar.2180.
Yates JW, Wallace Jr HJ, Ellison RR, Holland JF. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Cancer Chemother Rep. 1973; 57(4):485–8.
Kadia TM, Ravandi F, O’Brien S, Cortes J, Kantarjian HM. Progress in acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015; 15(3):139–51. DOI: 10.1016/j.clml.2014.08.006.
Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453–74. DOI: 10.1182/blood-2009–07–235358.
Burnett AK, Russell NH, Hills RK, Hunter AE, Kjeldsen L, Yin J et al. Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the Medical Research Council AML15 trial. J Clin Oncol. 2013;31(27):3360–8. DOI: 10.1200/JCO.2012.47.4874.
Borthakur G, Kantarjian H, Wang X, Plunkett Jr WK, Gandhi VV, Faderl S et al. Treatment of core‐binding‐factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event‐free survival. Cancer. 2008;113(11):3181–5. DOI: 10.1002/cncr.23927.
Acheampong DO, Adokoh CK, Asante DB, Asiamah EA, Barnie PA, Bonsu DOM et al. Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy. Biomed Pharmacother. 2018; 97:225–32. DOI: 10.1016/j.biopha.2017.10.100.
Cooper SL, Brown PA. Treatment of pediatric acute lymphoblastic leukemia. Pediatr Clin North Am. 2015;62(1):61–73. DOI: 10.1016/j.pcl.2014.09.006.
Siveen KS, Uddin S, Mohammad RM. Targeting acute myeloid leukemia stem cell signaling by natural products. Mol Cancer. 2017;16(1):13. DOI: 10.1186/s12943–016–0571-x.
Huber B, Eberl L, Feucht W, Polster J. Influence of polyphenols on bacterial biofilm formation and quorum-sensing. Z Naturforsch C J Biosci. 2003;58(11–12):879–84. DOI: 10.1515/znc-2003–11–1224.
Karakaya S, Koca M, Yılmaz SV, Yıldırım K, Pınar NM, Demirci B et al. Molecular docking studies of coumarins isolated from extracts and essential oils of zosima absinthifolia link as potential inhibitors for Alzheimer’s disease. Molecules. 2019;24(4):722. DOI: 10.3390/molecules24040722.
Siddique AB, Ebrahim H, Mohyeldin M, Qusa M, Batarseh Y, Fayyad A, et al. Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity. PLOS ONE. 2019;14(4):e0214798. DOI: 10.1371/journal.pone.0214798.
Bombardelli E. Phytosome: new cosmetic delivery system. Boll Chim Farm. 1991; 130(11): 431–8.
Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev. 2009;14(3):226–46.
Bombardelli E, Curri SB, Della Loggia R, Del Negro P, Gariboldi P, Tubaro A. Complexes between phospholipids and vegetal derivates of biological interest; 1989.
Hou Z, Li Y, Huang Y, Zhou C, Lin J, Wang Y, et al. Phytosomes loaded with Mitomycin C–soybean phosphatidylcholine complex developed for drug delivery. Mol Pharm. 2013;10(1):90–101. DOI: 10.1021/mp300489p.
Rafiei P, Haddadi A. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Int J Nanomedicine. 2017;12:935–47. DOI: 10.2147/IJN.S121881.
Wang Y, Tan Y. Enhanced drug loading capacity of 10-hydroxycamptothecin-loaded nanoparticles prepared by two-step nanoprecipitation method. J Drug Deliv Sci Technol. 2016; 36:183–91. DOI: 10.1016/j.jddst.2016.09.012.
Zhang D, Zhang J. Surface engineering of nanomaterials with phospholipid-polyethylene glycol-derived functional conjugates for molecular imaging and targeted therapy. Biomaterials. 2020; 230: 119646. DOI: 10.1016/j.biomaterials.2019.119646.
Dutta A, Patil RK, Pati HCl. Curcumin: its bioavailability and nanoparticle formulation: a review. Int J Health Sci Res. 2021; 11(10):228–38. DOI: 10.52403/ijhsr.20211030.
Mertins K, Iovel I, Kischel J, Zapf A, Beller M. Transition‐metal‐catalyzed benzylation of arenes and heteroarenes. Angew Chem Int Ed Engl. 2004; 44(2):238–42. DOI: 10.1002/anie.200460666.
Rajendar M, Saraswathi B. Preparation and optimization of diclofenac encapsulated liposomes using lipid hydration; 2014.
Guinedi AS, Mortada ND, Mansour S, Hathout RM. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 2005; 306(1–2):71–82. DOI: 10.1016/j.ijpharm.2005.09.023.
Ko YT, Bickel U. Liposome-encapsulated polyethylenimine/oligonucleotide polyplexes prepared by reverse-phase evaporation technique. AAPS Pharm Sci Tech. 2012; 13(2):373–8. DOI: 10.1208/s12249–012–9757–8.
Nele V, Holme MN, Kauscher U, Thomas MR, Doutch JJ, Stevens MM. Effect of formulation method, lipid composition, and pegylation on vesicle lamellarity: a small-angle neutron scattering study. Langmuir. 2019; 35(18):6064–74. DOI: 10.1021/acs.langmuir.8b04256.
Abdel-Fattah M, Saber M, Kantoush SA, Khalil MF, Sumi T, Sefelnasr AM. A hydrological and geomorphometric approach to understanding the generation of wadi flash floods. Water. 2017; 9(7):553. DOI: 10.3390/w9070553.
Telange DR, Patil AT, Pethe AM, Tatode AA, Anand S, Dave VS. Kaempferol-phospholipid complex: formulation, and evaluation of improved solubility, in vivo bioavailability, and antioxidant potential of kaempferol. J Excipients Food Chem. 2016;7(4):1174.
Kesharwani SS, Jain V, Dey S, Sharma S, Mallya P, Kumar VA. An overview of advanced formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of silymarin. J Drug Deliv Sci Technol. 2020; 60:102021. DOI: 10.1016/j.jddst.2020.102021.
Khan J, Alexander A, Ajazuddin S, Saraf S, Saraf S. Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives. J Control Release. 2013; 168(1):50–60. DOI: 10.1016/j.jconrel.2013.02.025.
Hatami A, Heydarinasab A, Akbarzadehkhiyavi A, Shariati FP. In vitro co-delivery evaluation of pegylated nano-liposome loaded by glycyrrhizic acid and cisplatin on cancer cell lines. J Nanopart Res. 2020; 22(9):1–12. DOI: 10.1007/s11051–020–04982–9.
Yu T, Wu C, Zhu C, He Y, Yang D, Cheng Y et al. Oral administration of liposome-apatinib and locally delivery of docetaxel/MPEG-PCL by fibrin glue synergistically improve therapeutic effect in colorectal cancer. J Biomed Nanotechnol. 2018; 14(12):2077–91. DOI: 10.1166/jbn.2018.2651.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497–506. DOI: 10.1016/S0140–6736(20)30183–5.
Upase AU, Bhusnure OG, Gholve SB, Giram PS, Wattamwar PB. A review on Phytosome loaded with novel herbal drug and their formulation, standardization and applications. J Drug Deliv Ther. 2019; 9(3-s):765–9.
Yu F, Li Y, Liu CS, Chen Q, Wang GH, Guo W, et al. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin. Int J Pharm. 2015; 484(1–2):181–91. DOI: 10.1016/j.ijpharm.2015.02.055.
Ahmad I, Akhter S, Anwar M, Zafar S, Sharma RK, Ali A et al. Supercritical anti-solvent technique assisted synthesis of thymoquinone liposomes for radioprotection: formulation optimization, in-vitro and in-vivo studies. Int J Pharm. 2017; 523(1):398–409. DOI: 10.1016/j.ijpharm.2017.03.052.
Alhakamy NA, A Fahmy U, Badr-Eldin SM, Ahmed OAA, Asfour HZ, Aldawsari HM et al. Optimized icariin phytosomes exhibit enhanced cytotoxicity and apoptosis-inducing activities in ovarian cancer cells. Pharmaceutics. 2020; 12(4):346. DOI: 10.3390/pharmaceutics12040346.
Lesoin L, Crampon C, Boutin O, Badens E. Preparation of liposomes using the supercritical anti-solvent (SAS) process and comparison with a conventional method. J Supercrit Fluids. 2011;57(2):162–74. DOI: 10.1016/j.supflu.2011.01.006.
Singh R, Upadhyay AK, Chandra P, Singh DP. Sodium chloride incites reactive oxygen species in green algae Chlorococcum humicola and Chlorella vulgaris: implication on lipid synthesis, mineral nutrients and antioxidant system. Bioresour Technol. 2018; 270:489–97. DOI: 10.1016/j.biortech.2018.09.065.
Lee CJ, Savani BN, Mohty M, Gorin NC, Labopin M, Ruggeri A, et al. Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2019;54(4):519–30. DOI: 10.1038/s41409–018–0286–2.
Singh V, Sahebkar A, Kesharwani P. Poly (propylene imine) dendrimer as an emerging polymeric nanocarrier for anticancer drug and gene delivery. Eur Polym J. 2021; 158:110683. DOI: 10.1016/j.eurpolymj.2021.110683.
Kesharwani SS, Bhat GJ. Formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of zerumbone. Medicina (Kaunas). 2020;56(11):557. DOI: 10.3390/medicina56110557.
Yu F, Ao M, Zheng X, Li N, Xia J, Li Y et al. PEG–lipid–PLGA hybrid nanoparticles loaded with berberine–phospholipid complex to facilitate the oral delivery efficiency. Drug Deliv. 2017; 24(1):825–33. DOI: 10.1080/10717544.2017.1321062.
Seca AML, Pinto DCGA. Plant secondary metabolites as anticancer agents: successes in clinical trials and therapeutic application. Int J Mol Sci. 2018; 19(1):263. DOI: 10.3390/ijms19010263.
Zhao QS, Hu LL, Wang ZD, Li ZP, Wang AW, Liu J. Resveratrol-loaded folic acid-grafted dextran stearate submicron particles exhibits enhanced antitumor efficacy in non-small cell lung cancers. Mater Sci Eng C Mater Biol Appl. 2017; 72: 185–91. DOI: 10.1016/j.msec.2016.10.077.
Yu F, Li Y, Chen Q, He Y, Wang H, Yang L et al. Monodisperse microparticles loaded with the self-assembled berberine-phospholipid complex-based phytosomes for improving oral bioavailability and enhancing hypoglycemic efficiency. Eur J Pharm Biopharm. 2016; 103:136–48. DOI: 10.1016/j.ejpb.2016.03.019.
DOI: https://doi.org/10.37591/nanotrends.v24i3.1395
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Nano Trends-A Journal of Nano Technology & Its Applications